Sunstone Capital is a Nordic-based early stage venture capital investor. The company has approximately EUR 400 million in funds under management.

Sunstone focuses on developing and expanding early-stage Life Science and Technology companies and invests primarily in communication technologies, components, software & digital media, medical technologies, pharmaceuticals, diagnostics and biotechnologies.